Headline News
Business·Industry
SK hynix to Invest 1,100 Trillion Won in Yongin, Cheongju, and the Southwest Region… A Hail-Mary Play for AI Memory
SK hynix has announced a mid- to long-term investment plan totaling 1,100 trillion won to meet growing demand for artificial intelligence (AI) memory. The strategy involves expanding its existing prod…
PHARM EDAILY
MARKET IN
RECENT NEWS
Entertainment
Broadcasting News
Oh Yoon-ah Remarries 11 Years After Divorce… “Recently Filed Marriage Registration”
Oh Yoon-ah. (Photo courtesy of Y.A. Entertainment)
A representative from Oh Yoon-ah’s agency, Y.A. Entertainment, revealed in a phone call with News1 on the 3rd, “Oh Yoon-ah recently registered he…
STOCK
K-SEMICONDUCTOR BRIEF
South Korea, Still Haunted by the '97 Trauma, Cautiously Launches 24-Hour Won Trading
Deep within the government complex in Sejong City, officials from the Ministry of Finance and Economy are monitoring every move of the won’s exchange rate from a room known as “the box.” With the won’…
Q2 Memory Market Forecast at 350 Trillion… 'Record-Breaking Boom' Amid Surge in DRAM and NAND Prices
The global memory semiconductor market is projected to reach nearly 350 trillion won in the second quarter of this year, driven by a sharp rise in memory prices resulting from increased investment in …
Most Read News
"Don't Worry" SK hynix's Target Price Raised Again to '4.2 Million Won'—KB
SamsungElectronics and SK Hynix '50x Leverage' Products: Koreans Cannot Invest
"Oral Insulin Developed After 35 Years of Waiting… Set to Be a Game-Changer"
Samsung Electronics' Q2 Operating Profit Exceeds 100 Trillion Won; INICS Corporation Likely to Post 80% Profit Margin
"From 1.8 million to 4 million won—still a bargain": SK hynix target price raised dramatically
Economy
Corporation
IT·Science
Economy
A Semiconductor Fabless Company Founded by SK Hynix’s Youngest-Ever Executive [VC Cradle]
The biggest bottleneck for AI servers is memory. As the KV cache—where large language models (LLMs) store past computations—accumulates, the required memory capacity increases exponentially. This prob…
Corporation
Genosco, Tax Risk?… “Lecraza Is ‘Royalty Income’; Its Value Remains Unchanged”
Concerns about “tax risks” have been raised in some quarters of the financial investment, pharmaceutical, and biotech markets regarding Genosco, a subsidiary of OSCOTEC Inc.(039200)specializing in new…
IT·Science
Celltrion Pharm Inc. Builds a Plant, AriBio Secures Investment… K-Bio in ‘Expansion Mode’ [Weekly Bio Roundup]
As July began (June 29–July 3), the pharmaceutical and biotech industries turned their attention to Celltrion Pharm Inc.’s large-scale investment in production facilities and AriBio’s successful fundr…
video
